For Healthcare Professionals
(This site is intended solely for the use of healthcare professionals)

Treat Flare Symptoms Where and When it Matters Most

Patients living with ulcerative colitis (UC) face the inevitability of flares. While flares often come without warning, patients seek immediate relief from the increased frequency and severity of their symptoms.

ROWASA® (mesalamine) Rectal Suspension Enema 4.0g/60mL convenience kit, providing fast, effective and soothing relief by going directly to the source of inflammation.

The Kit Includes:

  • ROWASA for the relief of flare symptoms associated with active mild to moderate distal UC, proctosigmoiditis, or ulcerative proctitis.
  • Plus, a daily, personal cleansing wipe that leaves UC patients clean
    and fresh.*

For your patients seeking more immediate relief, ROWASA:

Delivers medication to the site of inflammation in the rectum and colon – the places where it matters most.
Works topically, providing soothing flare relief when it matters most.
Significantly reduces rectal bleeding in as little as 3 days.1
Provides an effective treatment option you can rely on to manage flare symptoms.
Is available in an easy to administer bottle containing only 2 ounces of medication.
Offers convenient, once-nightly administration for greater flexibility to fit into a patient’s daily regimen.

1 Sutherland LR, Martin F, Greer S, et al. 5-aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology.
1987;92(6):1894-1898.

* Wipe is optional and not a required part of treatment.
Home  |  Stay Up-to-Date  |  About Alaven  |  Privacy Policy  |  Contact Us

Important Safety Information
Contraindications: ROWASA® (mesalamine) Rectal Suspension Enema is contraindicated for patients known to have hypersensitivity to the drug or any component of this medication.
Warning: ROWASA® (mesalamine) Rectal Suspension Enema contains potassium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown but probably low.
Precautions: Mesalamine has been implicated in the production of an acute intolerance syndrome characterized by cramping, acute abdominal pain and bloody diarrhea, sometimes fever, headache and a rash; in such cases prompt withdrawal is required. Caution should be exercised when mesalamine is initially used in patients known to be allergic to sulfasalazine.
Adverse Reactions: ROWASA® (mesalamine) Rectal Suspension Enema is usually well tolerated. Most adverse effects have been mild and transient. The most frequently reported adverse events include abdominal cramps, headache, gas, nausea, flu, fatigue, fever and rash.

The current formulation of ROWASA (mesalamine) is approved by the FDA for the treatment of mild to moderate distal ulcerative colitis, proctosigmoiditis, or ulcerative proctitis and is manufactured and marketed by Alaven Pharmaceutical. Click here for full prescribing information >>

© 2008 Alaven™ Pharmaceutical LLC, Marietta, GA. All rights reserved.
ROWASA® is a registered trademark of Alaven™ Pharmaceutical LLC.